Dengue Management: A Clinical Algorithm

Step 1: Suspect It

Jack Brown, 22, a college student from New York, visits your outpatient department in the second week of September. He has had three days of sudden high fever (103-104°F), a severe headache behind his eyes, intense body aches that make him feel like his bones are breaking, and mild nausea. His roommate had dengue two weeks ago. On examination, his blood pressure is 110/70, pulse rate is 94, and temperature is 102.8°F. No organ enlargement or rash is present yet.

Think of dengue until proven otherwise. The sudden onset, retro-orbital headache, and severe muscle pain disproportionate to the fever, combined with the time of year and direct contact with a confirmed case, suggest dengue unless lab results indicate otherwise. Use the DENGUE mnemonic as a quick bedside checklist:

- D — Dense fever, sudden onset

- E — Eye pain, retro-orbital

- N — Nausea and vomiting

- G — Generalized aches

- U — Rash or urticaria, which usually appears around days 3 to 4

- E — Epidemiological context — endemic area, monsoon season, contact history

Jack meets the criteria for D, E, G, and E. The rash has not appeared yet, which is normal on Day 3. You don’t need all six indicators; having a high suspicion in the right context is key.

Step 2: Diagnose Based on Day of Illness

Jack is on Day 3, so you decide to investigate. What tests should you order?

The dengue workup is not a fixed panel; it changes based on which day the patient presents.

Day 1 to 5 — Febrile Phase: 

- NS1 Antigen: This is the primary early marker. Its sensitivity peaks from Day 1 to 3 and drops sharply after Day 5.

- CBC with Differential: Leukopenia is an early sign, while thrombocytopenia appears around Days 3 to 4.

- PCV/Hematocrit: Record the baseline now. You’ll track changes daily to monitor for plasma leakage.

After Day 5 — Defervescence Phase: The fever breaks and patients feel better, but plasma leakage peaks during this time.

- IgM Antibody: Detectable from Days 5 to 6, confirming primary infection.

- IgG Antibody: If already elevated at presentation, it indicates secondary dengue and a higher risk of severe illness due to antibody-dependent enhancement. Manage these cases more aggressively from Day 1.

- LFT: AST/ALT levels at or above 1000 IU/L indicate severe liver involvement.

- RFT and Blood Glucose: Order if warning signs are present or if the patient is diabetic.

Results: NS1 positive, WBC 3,100 (indicating leukopenia), platelets 96,000 (mildly low), and PCV 38% (recorded as his baseline). Diagnosis confirmed: dengue fever. Now classify him.

Step 3: Classify the Patient

On Day 3, Jack has no abdominal pain, no vomiting, no bleeding, and no altered consciousness. He can drink fluids and his vital signs are stable.

Group A classification means no warning signs, stable, and tolerating oral fluids. He can be treated as an outpatient.

- Paracetamol only: maximum 60 mg/kg/day in children and 3 g/day in adults.

- NSAIDs and aspirin are strictly prohibited; they affect platelet function and increase bleeding risk. This is a common mistake in dengue management.

- Oral hydration: use ORS, coconut water, or juices.

- Daily CBC from Day 3 to monitor platelet and hematocrit trends.

- Clear instruction: return immediately if any warning signs appear.

Day 5: Jack returns looking worse. He has had severe abdominal pain since morning and has vomited four times in the last two hours. He is more fatigued than before. His BP is 100/70, and pulse rate is 104. Repeat CBC shows platelets at 38,000 and PCV now at 45%, up from his baseline of 38%.

Jack now has three warning signs: abdominal pain, persistent vomiting, and a rising hematocrit with falling platelets. 

He is now classified as Group B. 

Admit him immediately.

The seven warning signs that move a patient from Group A to Group B are:

1. Abdominal pain or tenderness

2. Persistent vomiting (three or more episodes in one hour)

3. Clinical fluid accumulation (ascites or pleural effusion)

4. Mucosal bleeding (gum bleeding or nosebleeds)

5. Lethargy, restlessness, or altered consciousness

6. Liver enlargement greater than 2 cm

7. Rising hematocrit with rapidly falling platelet count

Auto-classify to Group B even without warning signs if the patient is an infant, elderly, pregnant woman, obese, diabetic, has chronic kidney disease, chronic liver disease, or is on anticoagulants.

Group C includes patients with severe plasma leakage with shock (Dengue Shock Syndrome), active severe bleeding, or organ failure (AST/ALT above 1000, acute kidney injury, altered consciousness, or myocarditis). These patients go directly to the ICU and require immediate resuscitation with bolus IV fluids, escalating to colloids if the patient doesn’t improve.

Jack is admitted as a Group B patient, and you start IV fluids.

Fluid choice: Normal Saline or Ringer's Lactate. Aim for a urine output of at least 0.5 ml/kg/hr. The algorithm adjusts as the patient improves:

- Start with 5 to 7 ml/kg/hr for 1 to 2 hours, then reassess vitals and urine output.

- If improving, reduce to 3 to 5 ml/kg/hr for 2 to 4 hours and reassess.

- If stable, lower to 2 to 3 ml/kg/hr for 2 to 4 hours and reassess.

- If vitals and urine output return to normal, discontinue IV and switch to oral fluids.

- If not improving at any step, reevaluate for Group C.

Platelet transfusion: do not transfuse unless necessary. The threshold for transfusion is below 10,000/uL without bleeding or below 20,000/uL with minor bleeding. At 38,000, Jack does not need one yet.

Step 4: Monitor

Jack is on NS at 6 ml/kg/hr. After two hours, he looks better — abdominal pain has eased, no more vomiting, and his pulse rate is down to 90. By the evening of Day 5, platelets are 32,000 and PCV is 43%. On the morning of Day 6, platelets drop to 28,000 and PCV to 40%. He is afebrile for the first time, and urine output has been consistently good overnight.

The two critical numbers are hematocrit and platelet count. A rising hematocrit with a falling platelet count indicates active plasma leakage — escalate treatment immediately. Here’s what to track and how often:

- Vitals (BP, PR, RR, Temp): every 4 to 6 hours; every 1 to 2 hours in shock. Watch for narrowing pulse pressure, an early sign of shock before BP drops.

- Hematocrit (PCV): every 4 to 6 hours. A rise of more than 20% from the recorded baseline indicates significant leakage. Jack's baseline was 38%, and at 45%, he has crossed that threshold.

- Platelet Count: once or twice daily. Platelets may continue to fall for 1 to 2 days after admission before recovery. Do not panic at a falling platelet count in an otherwise stable patient.

- Urine Output: every 4 to 6 hours. Aim for 0.5 ml/kg/hr — this is your clearest real-time indicator of adequate blood flow.

- Blood Glucose: every 6 hours in Group C. Liver issues can lead to low blood sugar even in non-diabetic patients.

- LFT and RFT: daily in Group C. Keep an eye on AST/ALT and creatinine trends.

By the evening of Day 6: platelet count is 31,000 and starting to rise. PCV is back to 38%, his baseline, and he is asking for food. You stop IV fluids and switch to oral intake.

The increasing platelet count and normalizing hematocrit indicate the end of the leakage phase. At this point, taper and stop IV fluids. Around Days 5 to 7, leaked plasma begins to reabsorb back into the bloodstream. If IV fluids continue at this stage, you risk adding fluid to a system that is already refilling — leading to pulmonary edema. Taper as soon as the numbers and clinical picture improve.

Step 5: Discharge

Day 8: Jack has been afebrile for 52 hours without antipyretics. He has eaten full meals since yesterday. Platelet count is 64,000 and clearly on the rise, with a PCV of 37% and stable. There are no warning signs upon examination. Can he go home?

Yes, all five discharge criteria are satisfied:

1. Afebrile for at least 48 hours without antipyretics

2. No warning signs on clinical examination

3. Good appetite, adequate fluid intake, and stable urine output without IV fluids for at least 24 hours

4. Platelet count above 50,000/uL and trending upward

5. Hematocrit stable on serial readings

Discharge with instructions: no NSAIDs even for post-discharge aches, and return if any new fever or bleeding develops.

What You Must Never Do

- NSAIDs and Aspirin: These impair platelet function and increase the risk of gastrointestinal bleeding. Ask if the patient took any before coming in and stop them immediately.

- IM injections: These pose a risk of hematoma in a patient with low platelets.

- Prophylactic antibiotics: Dengue is viral with no bacterial target.

- Routine steroids: There is no evidence they help and they may cause harm.

- Prophylactic platelet transfusions above the threshold: This poses a risk of transfusion-related acute lung injury (TRALI) and fluid overload.

- Continuing IV fluids in the recovery phase: This can lead to pulmonary edema as reabsorption begins.

What Jack's Case Teaches Us

Jack came in as Group A and returned two days later as Group B. Classification is not a one-time event — it must be reassessed at every follow-up. The disease evolves, and your management must adjust accordingly.

Classify correctly. Monitor hematocrit closely. Taper fluids when the leakage phase ends. Do not discharge too early. Dengue only becomes dangerous if these steps are overlooked.

References

- NVBDCP. National Guidelines for Clinical Management of Dengue Fever. Revised edition.

- WHO. Dengue Guidelines for Diagnosis, Treatment, Prevention and Control. 2012.

- IAP Advisory on Dengue Fever Management.